Literature DB >> 26085002

Bone - a casualty of ICU survival?

Karin Amrein1, Astrid Fahrleitner-Pammer2, Hans Peter Dimai2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26085002      PMCID: PMC4472397          DOI: 10.1186/s13054-015-0977-7

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
We read with great interest the pilot study on fracture risk in 46 critically ill patients by Rawal and colleagues [1]. Bone mineral density (BMD) was assessed with portable calcaneal dual X-ray absorptiometry (DXA) on days 1 and 10. The authors found no overall change in BMD, but increased fracture risk in the subgroup with 'ARDS' (acute respiratory distress syndrome) (n = 34). There are several serious methodological problems: it is unclear if the group assignment is valid as only one of the four Berlin definition criteria [2] for the diagnosis of ARDS is given: oxygenation (no information on timing, chest imaging and origin of the edema). Although peripheral DXA devices are certainly an interesting option for BMD in critically ill and other patients [3], precision errors supplied by the manufacturer should not be used. In fact, each center must determine its (own) precision error and least significant change, which is also operator dependent [4]. The manufacturer stated a 0.9 % coefficient of variation, which is not necessarily applicable to the study setting where it remains unclear how the measurements were performed. This could be an important limitation. Hence, it is unlikely that a 2 % BMD change within such a short time frame as described would reflect anything else other than random variability. Lastly, it is also unclear what the described statistical difference refers to - it should be noted that the smaller subgroup (n = 12) numerically increased their BMD. Undoubtedly, fracture risk following critical illness is a very important topic that requires further high-quality studies [5].
  5 in total

1.  Bone loss during critical illness: a skeleton in the closet for the intensive care unit survivor?

Authors:  David M Griffith; Tim S Walsh
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

2.  The discriminatory capacity of BMD measurements by DXA and dual X-ray and laser (DXL) at the calcaneus including clinical risk factors for detecting patients with vertebral fractures.

Authors:  C Muschitz; H P Dimai; R Kocijan; A Kaider; A Zendeli; F Kühne; A Trubrich; S Lung; R Waneck; H Resch
Journal:  Osteoporos Int       Date:  2013-01-24       Impact factor: 4.507

3.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

Review 4.  Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry.

Authors:  John T Schousboe; John A Shepherd; John P Bilezikian; Sanford Baim
Journal:  J Clin Densitom       Date:  2013 Oct-Dec       Impact factor: 2.617

5.  A pilot study of change in fracture risk in patients with acute respiratory distress syndrome.

Authors:  Jaikitry Rawal; Mark J W McPhail; Gamumu Ratnayake; Pearl Chan; John Moxham; Stephen D R Harridge; Nicholas Hart; Hugh E Montgomery; Zudin A Puthucheary
Journal:  Crit Care       Date:  2015-04-14       Impact factor: 9.097

  5 in total
  2 in total

1.  The association of time and medications with changes in bone mineral density in the 2 years after critical illness.

Authors:  Neil R Orford; Michael Bailey; Rinaldo Bellomo; Julie A Pasco; Claire Cattigan; Tania Elderkin; Sharon L Brennan-Olsen; David J Cooper; Mark A Kotowicz
Journal:  Crit Care       Date:  2017-03-21       Impact factor: 9.097

Review 2.  Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa.

Authors:  K Amrein; A Papinutti; E Mathew; G Vila; D Parekh
Journal:  Endocr Connect       Date:  2018-12-01       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.